Improving reporting of adverse drug reactions: Systematic review

Improving reporting of adverse drug reactions: Systematic review

BACKGROUND Adverse drug reactions (ADRs) are a significant cause of morbidity and mortality, with many being identified post-marketing. Improvement in current ADR reporting, including utility of underused or innovative methods, is crucial to improve patient safety and public health. OBJECTIVES To evaluate methods to improve ADR reporting via a systematic literature review. METHODS Data sour...

Reporting adverse drug reactions.

and are available from booksellers through the network of WHO sales agents. A list of these agents may be obtained by writing to the above address. (CIOMS) is a nongovernmental organization established jointly by the World Health Organization and UNESCO in 1949, with a mandate to collaborate with the United Nations and its specialized agencies. Its international membership, consisting of intern...

Spontaneous reporting of adverse drug reactions.

Spontaneous reporting of fatal adverse drug reactions.

179 Many countries run schemes which encourage physicians and other health care professionals to report suspected drug reactions (ADRs). The aims of these spontaneous reporting schemes (SRSs) are to identify previously unsuspected reactions, to elucidate the relevant risk factors, and to evaluate the comparative toxicity of drugs within the same therapeutic class [1,2]. By their nature these sc...

Consumer reporting of adverse drug reactions

A ny new medication or therapy that has been approved for market authorization after extensive tests and trials is supposed to be efficient and, more importantly, safe. Yet, drug safety is not guaranteed: Many medications can still cause unexpected side effects that only come to light after approval. One of the worst examples is thalidomide, which caused severe birth defects and malformations i...